KATHRYN BOOR, PH.D.

Corporate Board Profile

Tech Score: 0/100

← Back to All Directors

Sarepta Therapeutics, Inc.

Filing Date Source Excerpt
2022-04-25 Kathryn Boor is a director nominee for Class I recommended by our nominating and corporate governance committee.

Source material: SEC submissions metadata and DEF 14A proxy filings from EDGAR. Last updated: 2026-03-22